A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods

Biopharmaceutics and Drug Disposition

Volumn 20, Issue 3, 1999, Pages 137-144

  Mahmood, Iftekhar ^a   Yuan, Rae ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Allometry; Apolysichron; Dienetichrons; Equivalent time; Kallynochron

Indexed keywords

CIPROFLOXACIN; CYCLOSPORIN; ETHOSUXIMIDE;

ALLOMETRY; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; NONHUMAN; PREDICTION;

ANIMALS; BODY WEIGHT; HALF-LIFE; HUMANS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 0033026297     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199904)20:3<137::AID-BDD165>3.0.CO;2-I     Document Type: Article

References (24)

1. Mordenti J. Man versus beast. J Pharm Sci 1986; 75: 1028-1040.
2. Dedrick RL. Animal scale-up. J Pharmacokin Biopharm 1973; 1: 435-461.
3. Boxenbaum H. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab Rev 1984; 15: 1071-1121.
4. Boxenbaum H. Interspecies scaling, allometry, physiological time and the ground plan of pharmacokinetics. J Pharmacokin Biopharm 1982; 10: 201-227.
5. McNamara PJ. Interspecies scaling in pharmacokinetics. In: Welling PG, Tse FLS, Dighe SV (eds) Pharmaceutical Bioequivalence. New York: Marcel Dekker, 1991; 267-300.
6. Mahmood I, Balian JD. Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance. J Pharm Sci 1996; 85: 411-414.
7. Mahmood I, Balian JD. Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica 1996; 26: 887-895.
8. Houston B. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 1994; 47: 1469-1479.
9. Swab E, Bonner D. Prediction of aztreonam pharmacokinetics in humans based on data from animals. J Pharmacokinet Biopharm 1983; 11: 215-223.
10. Mordenti J. Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from human data. J Pharm Sci 1985; 74: 1097-1099.
11. Dedrick RL, Bischoff KB, Zaharko DZ. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother Rep (Part 1) 1970; 54: 95-101.
12. Hutchaleelaha A, Chow H, Mayersohn M. Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species. J Pharm Pharmacol 1997; 49: 178-183.
13. Lave T, Saner A, Coassolo P, Brandt R, Schmitt-Hoffmann AH, Chou RC. Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor. J Pharm Pharmacol 1996; 48: 573-577.
14. Mehta SC, Lu DR. Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans. Biopharm Drug Dispos 1995; 16: 735-744.
15. EL Sayed MA, Loscher W, Frey HH. Pharmacokinetics of ethosuximide in the dog. Arch Int Pharmacodyn 1978; 234: 180-192.
16. Sangaili L, Bortollotti A, Jiritano L, Bonati M. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans. Drug Metab Dispos 1988; 16: 749-753.
17. Gridelli B, Scanlon L, Pellicci R, Lapointe R, Dewolf A, Seltman H, Diven W, Shaw B, Starzi T, Sanghvi A. Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog. Transplantation 1986; 41: 388-391.
18. Awani WM, Sawchuk RJ. The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion in the rabbit. Drug Metab Dispos 1985; 13: 127-132.
19. Siefert HM, Maruhn D, Maul W, Forster D, Ritter W. Pharmacokinetics of ciprofloxacin. Arzheim-Forsch 1986; 36: 1496-1502.
20. Abadia AR, Aramayona JJ, Munoz MJ, Pladelfina JM, Saez MP, Bregante MA. Disposition of ciprofloxacin following intravenous administration in dogs. J Vet Pharmacol Therap 1994; 17: 384-388.
21. Aramayona JJ, Mora J, Fraile LJ, Garcia MA, Abadia AR, Bregante MA. Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. Am J Vet Res 1996; 57: 547-553.
22. Drusano GL, Plaisance KI, Forrest A, Standiford HC. Dose ranging study and constant infusion evaluation of ciprofloxacin. Antimicrob Agents Chemother 1986; 30: 440-443.
23. Sacher G, CIBA Foundation Colloquia on Aging, Wolstenholme GEW, O'Connor M (eds). London: Churchill, 1959; 115-133.
24. Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's, The Pharmacological basis of Therapeutics. Eighth edition. New York: McGraw-Hill, 1993; 1674, 1680.